The global equine supplement product market is expected to grow at a significant CAGR during the forecast period (2021-2027). Equine infectious anaemia (EIA) is a retroviral illness that causes equids to develop acute and/or chronic recurring clinical symptoms such as fever and anemia. Equine infectious anemia virus can be found in horses and ponies, as well as mules, enema, and cachexia. A supplement is given to an animal suffering from equine sickness in order to complete something, make up for a deficit, or to extend or strengthen the whole. The prevalence of equines has increased in the recent decade. Equine infectious anaemia has been discovered almost everywhere. In a few nations, such as Iceland and Japan, the condition appears to be rare or non-existent. 

As a result, the sickness spread like an equine disease. Initiative programs such as the "Equine Disease Communication Centre" aim to alleviate the health, welfare, and economic consequences of these occurrences for US horses and the industry as a whole, which is expected to reduce the risk of equine disease, hence spurring the growth of equine supplements. The only thing that can assist is taking extra vitamins or minerals. This, in turn, is contributing to the demand for equine supplement products. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Zoetis Inc., Boehringer Ingelheim International GmbH, Bayer AG, Equine Products UK LTD., among others. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Global Equine Supplement Product Market Report Segmentation

By Supplement 

• Proteins/Amino Acids

• Vitamins

• Enzymes

• Electrolytes/Minerals 

By Application 

• Performance Enhancement/Recovery 

• Join Disorder Prevention

• Others

Global Equine Supplement Product Market by Region